Stock Details
BAYZF is Bayer Aktiengesellschaft's stock. Stock exchange Other OTC (Currency USD). Average price in 50 days is 65.87$. Average daily volumn in 3 months 7.57k. Market cap 56.90B



Stock symbol : BAYZF. Exchange : Other OTC. Currency : USD
Lastest price : 55.69$. Total volume : 10.42k. Market state PRE
Click reload if you want to check the lastest price on market!!!

Bayer Aktiengesellschaft (BAYZF)
Last Price
55.69$
Change
-3.08
Volume
10.42k

Previous Close58.77
Open57.00
Day Range55.69-57.00
Bid0.00 x N/A
Ask0.00 x N/A
Volume10.42k
Average Volume7.57k
Market Cap56.9B
Beta1.12
52 Week Range50.21-74.34
Trailing P/E23.80
Foward P/EN/A
Dividend (Yield %)3.78%
Ex-Dividend Date2022-05-02



Financial Details



Organization

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescr... iption over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Market Cap:
56.90B
Revenue:
44.08B
Total Assets:
120.24B
Total Cash:
4.56B


News about "Bayer Aktiengesellschaft"

bayer-aktiengesellschaft-otcmktsbayry-receives-consensus-recommendation-of-moderate-buy-from-analysts-image

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Receives Consensus Recommendation of โ€œModerate Buyโ€ from Analysts

Source from : Defense World - 5 days ago

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY โ€“ Get Rating) have been assigned a consensus recommendation of โ€œModerate Buyโ€ from the ten brokerages that are presently covering the company, ...See details»


bayer-aktiengesellschaft-otcmktsbayry-short-interest-up-1097-in-june-image

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Up 109.7% in June

Source from : Defense World - 5 days ago

Bayer Aktiengesellschaft (OTCMKTS:BAYRY โ€“ Get Rating) saw a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 282,400 shares, a growth of 109.7% ...See details»


bayer-riskreward-skewed-to-the-upside-image

Bayer: Risk/Reward Skewed To The Upside

Source from : Seeking Alpha - 4 days ago

Bayer is a global company with a portfolio of valuable intellectual property, but the stock is trading very cheap according to me. Click here to know why.See details»


us-supreme-court-again-nixes-bayer-challenge-to-weedkiller-suits-image

U.S. Supreme Court again nixes Bayer challenge to weedkiller suits

Source from : Reuters - 8 days ago

The U.S. Supreme Court on Monday rejected another Bayer AG bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries to avoid ...See details»


bayer-ag-opens-kendall-square-research-center-focused-on-cancer-image

Bayer AG opens Kendall Square research center focused on cancer

Source from : The Boston Globe on MSN.com - 6 days ago

The German company says the space will help it โ€˜double downโ€™ on partnerships with local universities and biotechs.See details»


bayer-loses-again-as-us-supreme-court-rejects-challenge-to-roundup-lawsuits-image

Bayer loses again as U.S. Supreme Court rejects challenge to Roundup lawsuits

Source from : The Business Journals - 8 days ago

Bayer, the German successor to Monsanto with its crop science headquarters in St. Louis, said Monday it โ€œrespectfully disagrees with the Supreme Courtโ€™s decision, but the company is not surprised ...See details»


Fact Check-Bayer executiveโ€™s comments misinterpreted in social media posts

Source from : Reuters - 8 days ago

Remarks by Bayer executive Stefan Oelrich in 2021 have been shared on social media to spread the false allegation that COVID-19 mRNA vaccines are a form of gene therapy. Contrary to claims online, ...See details»


Bayer loses second case in a week

Source from : Markets - 8 days ago

The U.S. Supreme Court let stand an $87 million award against Bayer AG, rejecting the company for the second time in a week as it tries to fend off tens of thousands of claims that its top-selling ...See details»


bayer-appeal-to-dismiss-roundup-weedkiller-lawsuits-rejected-by-us-supreme-court-image

Bayer appeal to dismiss Roundup weedkiller lawsuits rejected by U.S. Supreme Court

Source from : NationofChange - 12 days ago

The U.S. Supreme Court has rejected an appeal by German company Bayer AG to dismiss legal claims by customers who assert one of its products โ€” glyphosate-based Roundup weedkiller โ€” causes cancer. The ...See details»


us-supreme-court-denies-bayer-appeal-of-weed-killer-cancer-suit-image

US Supreme Court denies Bayer appeal of weed killer cancer suit

Source from : Jurist - 13 days ago

The US Supreme Court Tuesday denied Bayer AG's appeal of a $25 million judgment against it from the US Court of Appeals for the Ninth Circuit. Bayer's appeal attempted to dismiss all legal claims ...See details»


bayer-opens-new-research-and-innovation-center-at-kendall-square-image

Bayer Opens New Research and Innovation Center at Kendall Square

Source from : Contract Pharma - 5 days ago

New center of precision molecular oncology research equipped with state-of-the-art labs and offices for the development of targeted cancer therapies.See details»


cytiva-and-bayer-agree-to-collaborate-on-allogeneic-cell-therapy-manufacturing-platform-image

Cytiva and Bayer Agree to Collaborate on Allogeneic Cell Therapy Manufacturing Platform

Source from : GEN - 1 days ago

Cytiva and Bayer will provide personnel, resources, and facilities to work on the joint development program. Bayerโ€™s road map for allogeneic cell therapy manufacturing technology will be leveraged, ...See details»


cytiva-and-bayer-partner-to-develop-allogenic-cell-therapy-platform-image

Cytiva and Bayer partner to develop allogenic cell therapy platform

Source from : BioProcess International - 1 days ago

Cytiva and Bayer have partnered to develop what they claim is the first modular end-to-end platform for allogenic cell therapies.See details»


ag-groups-dismayed-by-supreme-court-glyphosate-decision-image

Ag groups dismayed by Supreme Court glyphosate decision

Source from : The Journal - 12 days ago

A fast-moving and complex legal and regulatory landscape has left the state of affairs on glyphosate products, including Bayerโ€™s flagship product Roundup, more conflicted than ever. While Bayer has wo ...See details»